跳至主要内容
临床试验/NCT01669460
NCT01669460已完成2 期

A Phase II, Open Label Study of Red Bull™ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy

University Health Network, Toronto2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2012年7月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
20
试验地点
2
主要终点
Reduction in overall fatigue as measured by Bruera global fatigue severity scale.

研究概览

简要总结

The purpose of this research study is to find out if Red Bull™ Sugar-Free Drink can reduce fatigue in prostate cancer patients receiving LHRH agonist therapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Histologically confirmed prostate cancer
  • Currently receiving LHRH-agonist therapy for greater than 6 months
  • Measurable fatigue, defined as a score of ≥ 2 on the Bruera global fatigue severity scale
  • Able to swallow Red Bull™ Sugar-Free Drink
  • Life expectancy of at least 1 year
  • Able to read and write in English
  • Willing to limit consumption of alcohol to one drink per day

排除标准

  • Current malignancy or received treatment for a previous malignancy within the last 3 years other than prostate cancer (exceptions are superficial bladder cancer or non-melanoma skin cancer)
  • Myocardial infarction within past 6 months
  • Any unstable serious co-existing medical condition(s) including but not limited to unstable or poorly controlled coronary artery disease, chronic atrial fibrillation, uncontrolled hypertension, uncontrolled diabetes, severe bleeding diseases or immune disorders
  • Evidence of drug or alcohol abuse
  • Known hypersensitivity to caffeine
  • Known history of liver and kidney insufficiencies
  • Known contraindications to Red Bull™ use

结局指标

主要结局

Reduction in overall fatigue as measured by Bruera global fatigue severity scale.

时间窗: Within 4 days after completion of intervention (28 days of Red Bull™)

次要结局

  • Overall improvement in quality of life as measured by the Medical Outcomes Study Short-Form (SF-36)(Within 4 days after completion of intervention (28 days of Red Bull™))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验